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Tricresyl Phosphate Neurotoxicity Potential*
George William Sherk**
I can't eat, I can't talk
Been drinking mean Jake,
Lord now I can't walk.
Ain't got nothing, count to lose
'Cause I'm a lake walking papa
with the jake Walk Blues.
Introduction
The Allen Brothers recorded "Jake Walk Blues" in May, 1930.
"Jamaican Ginger" (or "Ginger Jake" or simply "Jake") was an over-the-
counter remedy whose success in treating a variety of ailments may
have resulted from its 70-80% alcohol content.' Such "medicinals"
were popular during Prohibition, especially among the poor of the rural
South and Midwest.2
Hub Products Corporation produced one particular batch of "Jake"
(enough for 640,000 two-ounce bottles) using Lindol instead of castor
oil as a solvent. The Lindol contained tri-ortho-cresyl phosphate
(TOCP), a neurotoxicant. As a result, between 1930 and 1931, an
estimated 40,000 to 50,000 people ingested "Jake" contaminated with
TOCP, the consequences of which, "a severe central peripheral distal
axonopathy," are reflected in the Allen Brothers' song.3
* This paper, prepared for Dr. Philip A. Edelman, Dept. Environmental &
Occupational Health, School of Public Health and Health Services, George
Washington University received second prize in the 1999 Risk student wtiting
competition. The assistance of Ms. Susan Buyer, Acting Chief, Office of Planning and
Analysis, National Library of Medicine is appreciated; she deserves much credit and
no blame.
** Mr. Sherk is a D.Sc. Candidate, Department of Engineering Management and
Systems Engineering, George Washington University. Email: gwsherk@cais.com.
1 See Alan D. Woolf, Ginger Jake and the Blues: A Tragic Song of Poisoning, 37
Vet. & Hum. Tox. 252 (1995).
2 Id; see also Douglas C. Anthony, Thomas J. Montine & Doyle G. Graham,
Toxic Responses of the Nervous System, in Casarett & Doul's Toxicology: The
Basic Science of Poisons (6th ed., 1996).
3 Supra note 1.
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These consequences resulted from the process by which "Jake" was
produced. While "Jake" has long since departed the marketplace, there
are other products that expose individuals to TOCP. Once again,
TOCP exposure may result from the process by which specific
products are manufactured.
One of these products is tricresyl phosphate (TCP), a
nonflammable, nonexplosive, colorless, viscous fluid.4 It is utilized as
a vinyl plasticizer, a fire retardant, a high performance lubricant and as
an anti-wear additive. 5 Mostly, TCP was developed to meet aviation
safety and performance requirements. Consequently, it is a common
component of a variety of aircraft lubricating and hydraulic fluids.6
In addition, TCP is used in cutting oils, machine oils, extreme high
pressure fluids, automobile transmission fluids and certain cooling
lubricants. 7 It is also used in the making of synthetic leather and
polyvinyl acetate products as well as in the manufacture of the interior
components of automobiles. In fact, "TCP can evaporate from
automobile upholstery fabrics and condense on the interior surface of a
relatively cool window." 8
The production process for commercial grade TCP utilizes
technical grade cresols (methyl phenols) produced through the
distillation of hydrocarbons. Because commercial grade TCP utilizes
natural sources of cresols, a number of unwanted components may be
contained in the final product. These unwanted components may
include up to ten TCP isomers, one of which is TOCP.
4 See World Health Organization (WHO) Working Group, Tricresyl Phosphate,
Env. Health Criteria at 110 (1990).
5 Id.; see also J.R. Latendresse, C.L. Brooks & C.C. Capen, Toxic Effects of
Butylated Triphenyl Phosphate-Based Hydraulic Fluid and Tricresyl Phosphate in
Female P344 Rats, 32 Vet. Path. 394 (1995); see also Michael P. Marino,
Phosphate Esters, in Synthetic Lubricants and High-Performance Functional Fluids
(1992); see also Hideo Kurebayashi, Akira Tanaka & Tsutomu Yamaha,
Metabolism and Disposition of the Flame Retardant Plasticizer, Tri-p-cresyl
Phosphate, in the Rat, 77 Tox. & App. Pharm. 395 (1985).
6 See supra, Marino.
7 See WHO, supra note 4; see also National Toxicology Program (NTP)
Working Group, Toxicology and Carcinogenesis Studies of Tricresyl Phosphate in
F344/N Rats and B6C3F Mice (Gavage and Feed Studies), 433 Nat'l Tox. Prog.
Tech. Rep. (1994).
8 WHO, supra note 4.
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This report addresses the potential neurotoxicity of the ten isomers
that may be contained in commercial grade TCP. The process by
which the isomers are created is described in the following section.
Section III reviews the absorption, distribution, metabolism and
excretion of the isomers. The potential neurotoxicity of isomers
containing an ortho-methyl group is reviewed in Section IV and
discussed in Section V. Conclusions are presented in Section VI.
The Production Process
The production process begins with the distillation of
hydrocarbons, usually coal tar or the residue from coke ovens and
petroleum refining. 9 Primary distillation of these hydrocarbons
produces crude cresylic acids (or "tar acids"). Fractionation of these
acids then yields crude phenol (including fluids high in ortho cresol
content), a mixture of isomeric cresols and a crude meta/para cresol
fraction. 10
Redistillation of the meta/para cresol fraction yields two cresol
isomers, either a product containing at least 50% meta cresol or a
product containing 58%-60% meta cresol and 40%-42% para cresol.
Both of these products may contain small amounts (<1%) of ortho
cresol. A number of other substances may be present, depending on the
temperature of distillation (different substances having different boiling
points), the specific distillation process utilized and the content of the
hydrocarbon feedstock.1 1 The substances likely to be present in the
two cresol isomers include ortho cresol (2-methyl phenol), meta
cresol (3-methyl phenol), para cresol (4-methyl phenol), 2, 3-xylenol
(2, 3-dimethyl phenol), 2, 4-xylenol (2, 4-dimethyl phenol), 2, 5-
xylenol (2, 5-dimethyl phenol), 2, 6-xylenol (2, 6-dimethyl phenol), 3,
4-xylenol (3, 4-dimethyl phenol), 3, 5-xylenol (3, 5-dimethyl phenol),
ortho ethyl phenol (2-ethyl phenol), meta ethyl phenol (3-ethyl




11 Marino, supra note 5.
12 Proprietary source.
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After the redistillation process is complete, either of the two cresol
isomers is combined with phosphorus oxychloride (POC13 ) to produce
commercial grade TCP. 13 As noted above, because the two cresol
isomers are derived from various natural sources, a number of unwanted
components may be contained in the isomers. In essence, "the
composition of the final product depends on the isomeric composition
of the cresol preparation[.]" 14
These unwanted components may include as many as ten
"structurally distinguishable triesters of cresol and phosphoric acid." 15
The isomers are distinguished by the location of the methyl group on
the phenyl ring in any of the ortho, meta or para positions. 1 6
Figures 1 through 3 represent pure tri-isomer triesters:
Figure 1: Tri-ortho-cresyl phosphate (TOCP)
0
oK
CH 3  0 CH3
0
CH3






13 WH-O, supra note 4; see also NTP, supra note 7.
14 NTP, supra note 7.
15 Id.
16 Marino, supra note 5.
Sherk Tricresyl Phosphate Neurotoxicity 155
Figure 3: Tri-para-cresyl phosphate (TPCP)
H3 C 0 H3
0
CH 3
Figures 4 through 9 are mixed di- and mono-isomers:
Figure 4: Di-ortho -cresyl-meta-cresyl phosphate
I I
0
O'0 0 CH 3
CH3 
0 NO




Figure 6: Di-meta-cresyl- ortho-cresyl phosphate
0
H3  1 0 GCl3
M0
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Figure 7: Di-meta-cresyl-para-cresyl phosphate
H 3
H3 C 0 H
PxO0 o/\
Figure 8: Di-para-cresyl- ortho-cresyl phosphate
0 CH 3
CH3 0) CH3
Figure 9: Di-para-cresyl-meta-cresyl phosphate
CH 3 , , 0 iCH3
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Last is a mixed tri-isomer:




Absorption, Distribution, Metabolism and Excretion
Understanding the absorption, distribution, metabolism and
excretion of organophosphates such as TCP is critical to understanding
the delayed neuropathic effects that may result from exposure to these
compounds. 17 Unfortunately, of the ten TCP isomers, virtually all
studies conducted to date have focused on the pure tri-isomers, with
TOCP (Figure 1) receiving significantly greater attention than either
TMCP (Figure 2) or TPCP (Figure 3). There are very few studies that
"attempt[] to characterize the metabolism of tricresyl phosphate
prepared from mixed isomers."1 8
Absorption
TOCP, TMCP or TPCP may enter the body by a number of
pathways. A primary means is absorption through the skin. 19 Animal
studies have shown that TOCP is readily absorbed following dermal
application. 20 With regard to TMCP and TPCP, "the similarity of
structure and physical properties (solubility, etc.) make it likely that
these compounds are also absorbed through the skin."2 1
All three isomers may be absorbed through both the lungs and the
gastrointestinal tract. 22 There have been multiple cases of accidental
17 WHO, supra note 4.
18 NTP, supra note 7.
19 See Latendresse, supra note 5; see also WHO, supra note 4; see also NTP,
supra note 7; see also Mohamed B. Abou-Donia & Daniel M. Lapadula,
Mechanisms of Organophosphorus Ester-induced Delayed Neurotoxicity: Type I
and Type II, 30 Ann. Rev. Pharm. & Tox. 405 (1990).
20 See WHO, supra note 4; see also NTP, supra note 7.
21 See NTP, supra note 7.
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ingestion of hydraulic fluid, lubricating oil or mineral oil containing
TCP. Several incidents have also been reported where cooking oil or
flour contaminated with hydraulic fluid or lubricating oil led to the
ingestion of TCP.23
Distribution
The NTP Working Group noted that TOCP, TMCP and TPCP
are distributed rapidly to the liver and muscle. Thereafter, all three
isomers are redistributed to adipose tissue and to skin.24
Citing an earlier study, the WHO Working Group noted
distribution of TOCP in the following descending order: Liver > blood
> kidney > lung > muscle or spinal cord > brain or sciatic nerve. Ten
days post-exposure, the highest levels of TOCP were found in the bile,
gall bladder, urinary bladder, kidney and liver with only small amounts
being detected in the spinal cord or brain.25
Metabolism
The initial step in the metabolism of TOCP appears to be the
oxidation of one or more of the ortho-cresyl groups to produce
ortho-hydroxy benzyl alcohol (saligenin) residue. This reaction, which
occurs in the liver, appears to be catalyzed by the microsomal mixed-
function oxidase system. Once this reaction has occurred, the ortho-
hydroxy benzyl alcohol (saligenin) residue cyclizes via an internal group
displacement reaction and displaces the remaining ortho-cresyl
groups. 2 6 This process leads to the formation of saligenin cyclic
ortho-totyl phosphate (cyclic phosphate), a relatively unstable
neurotoxic metabolite that is hydrolyzed rapidly to inactive metabolic
products and does not bioaccumulate in the body.2 7 It is interesting to
note that animal studies (utilizing chickens) show the metabolite
(saligenin cyclic ortho-totyl phosphate) is at least five times more toxic
than the parent compound (TOCP).2 8
22 See Latendresse, supra note 5.
23 See WHO, supra note 4; see also NTP, supra note 7.
24 See NTP, supra note 7.
25 See WHO, supra note 4.
26 See NTP, supra note 7.
27 See WHO, supra note 4.
28 Id.
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The process by which saligenin cyclic ortho-totyl phosphate (cyclic
phosphate) is formed does not occur when TPCP is metabolized. This
result is because the cyclization process described above does not occur,
apparently because the methyl group is positioned so that the resulting
para-hydroxy benzyl alcohol residue cannot participate in the
cyclization process (see Figure 3). 2 9
Though the metabolism of TMCP has not been studied
extensively, the position of the methyl group in TMCP is similar to the
position of the methyl group in TPCP (see Figure 2). Consequently, it
may be presumed that the metabolic processes are also similar.3 0
Excretion
Animal studies indicate that TOCP is excreted primarily in the
urine (70%) within 24 hours of dosage. With regard to TPCP, the final
product of the metabolic process is para-hydroxy benzoic acid,
excreted primarily in the urine. Animal studies, however, indicate that
this may vary according to dose, with higher doses of TPCP excreted
in the feces. Given the structural similarity between TPCP and TMCP,
it is somewhat surprising that animal studies indicate that the primary
means of excreting TMCP is in the feces; as with TPCP, however, the
amount excreted in the feces increased with higher doses of TMCP.3 1
The Ortho-Methyl Group
There is general agreement that TOCP (Figure 1) is significantly
more toxic than either TMCP (Figure 2) or TPCP (Figure 3). The
central and peripheral nervous systems are especially sensitive to TOCP
toxicity.32 It has been known since the 1930s that TOCP produces
peripheral neuropathy in humans. 33 The peripheral neuropathy caused
by exposure to TOCP is characterized by a one to three week delay in
the onset of symptoms. As a result, it is referred to as
29 See NTP, supra note 7; see also Kurebayashi supra note 5.
30 See NTP, supra note 7.
31 Id.
32 The reproductive system is also particularly vulnerable; see NTP, supra note 7;
see also Latendresse, supra note 5; see also WHO, supra note 4; see also
Sajalendu Nanda & Pranab Kumar Tapaswi, Biochemical, Neuropathological and
Behavioral Studies in Hens Induced by Acute Exposure of Tri-ortho-cresyl
Phosphate, 82 IntlJ. Neuro. 243 (1995).
33 See Anthony et al., supra note 2; see also NTP, supra note 7.
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"organophosphate-induced delayed neurotoxicity" (OPIDN) and is
classified as "dying-back neuropathy.' '34 TOCP has been defined as
"one of the more potent OPIDN neurotoxins in humans."35
Several of the triaryl phosphates (including TOCP) are known to be
esterase inhibitors.3 6 Inhibition of neurotoxic esterase (NTE) below a
critical threshold level is thought to be the biochemical lesion leading to
OPIDN.37 NTE inhibition after exposure to TOCP, which appears to
be a function of dosage, presages subsequent neuropathy.3 8 In terms of
defining the critical threshold level, studies by Daughtrey et al. have
concluded (a) that a 70% NTE inhibition level is necessary "for the
induction of OPDIN in hens" following acute exposure to TOCP and
(b) that "NTE inhibiting in the range of 45 to 65% is necessary to elicit
neuropathic effects" following repeated exposure to TOCP.
Initial symptoms include muscle cramps and soreness as well as
weakness of leg muscles. These symptoms may progress to partial
paralysis of the extremities (mild cases) or to complete paralysis (severe
cases). The upper extremities may not even be involved initially.
However, the more severe the case, the more likely that the upper
extremities will become involved and the less likely that there will be a
full clinical recovery. The neurological disorder in severe cases may
persist for decades.3 9
34 See WHO, supra note 4; see also Marino supra note 5; see also Abou-Donia,
supra note 19; see also Werner Classen et al., Susceptibility of Various Areas of the
Nervous System of Hens to TOCP-induced Delayed Neuropathy, 17 Neurotox.
597 (1996); see also E.R. Kinkead et al., The Acute Delayed Neurotoxicity
Evaluation of Two Jet Engine Oil Formulations, Nat'l Tech. Info. Service
(ADA222018) (1990).
35 Marino, supra note 5.
36 See Latendresse, supra note 5.
37 See Abou-Donia, supra note 19; see also Nanda, supra note 32; see also
Classen stupra note 34; see also Kinkead supra note 34; see also Mushtaq A. Saleem
et al., Effect of Tri-o-cresyl Phosphate (TOCP) on Proteolytic Enzyme Activities in
Mouse Liver in vivo, 17 J. Envtl. Path. Tox. & Oncology 69 (1998); see also Wayne
Daughtrey et al., Subchronic Delayed Neurotoxicity Evaluation of Jet Engine
Lubricants Containing Phosphorus Additives, 32 Fund. & App. Tox. 244 (1996);
See Martin K. Johnson, Organophosphates and Delayed Neuropathy: Is NTE Alive
and Well? 102 Tox. & App. Pharm. 
385 (1990).
38 See WHO, supra note 4; see also Nanda, supra note 32; see also Kinkead,
supra note 34; see also Johnson, supra note 37.
39 See WHO, supra note 4; see also NTP, supra note 7; see also Abou-Donia,
note 19.
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The NTP Working Group addressed the delayed neurotoxicity
associated with exposure to TOCP. In its final report, the Working
Group noted that "the onset of delayed neurotoxicity is associated with
the presence of a distal axonopathy which is most prominent in long,
large diameter myelinated axons of peripheral nerves and long spinal
tracts." 4 0 The Working Group then described the distal
axonopathy/recovery process as follows: 41
The axonopathy begins initially as a nonterminal focal lesion
resembling a transection of the axon, the portion of the
severed axon distal to the site of transection then
degenerates followed by degeneration of the myelin sheath
surrounding the distal portion of the neuron. During the
period of clinical recovery, peripheral nerve fibers regenerate
relatively quickly (weeks), however recovery of long spinal
tracts occurs much more slowly or not at all.
In essence, axonal degeneration ("giant axonal swelling" according
to Abou-Donia et al.) and "subsequent degeneration of the myelin in
the most distal portion of large diameter, long axons in the peripheral
and in the spinal cord motor and sensory tracts" result from exposure
to the metabolite saligenin cyclic ortho-totyl phosphate, the active
neurotoxic agent.42 Regarding metabolism of TCP, this metabolite is
produced only when an ortho-methyl group is present.4 3
With regard to the ten TCP isomers, TOCP contains three ortho-
methyl groups. Such groups are not contained in either TMCP or
TPCP. This explains why "[o]nly tricresyl phosphates in which at least
one of the cresol residues is an ortho-isomer are neurotoxic; triesters
which contain only meta- orpara- isomers (or both) are not
neurotoxic." 4 4 In essence, when TCP is synthesized with para-cresol
or meta-cresol, it is not neurotoxic. 45
40 NTP, supra note 7.
41 Id. (internal citations omitted).
42 See WHO, supra note 4; see also Nanda, supra note 32.
43 The nomenclature on this point is inconsistent. Abou-Donia et al., note 19, refer
to the required presence of an ortho-methyl group. Marino, note 5, indicates that
this is the correct reference. However, the NTP Working Group, note 7, refers to the
required presence of either ortho-cresol or of an ortho-isomer and the WHO
Working Group, note 4, refers to the required presence of an ortho-totyl group.
44 NTP, supra note 7.
45 See Kurebayashi, supra note 5.
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Discussion
The metabolic process described in the preceding section "could
occur whenever one of the cresol groups esterified to phosphoric acid
was ortho-cresol.' '4 6 In fact, animal studies indicate that "preparations
in which ortho-cresol was present predominantly as a mono-ester, with
the remaining two positions being occupied by meta- and/or para-
cresol, were more neurotoxic to chickens than preparations containing
predominantly tri-ortho-cresyl phosphate." 4 7  Furthermore,
"preparations composed of ortho-cresol containing mixed triesters
exhibit toxicity similar to that usually associated with tri-ortho-cresyl
phosphate." 4 8 The WHO Working Group reached the same
conclusion, noting that mixed ortho-cresyl esters "are also toxic and
contribute to the neurotoxic action." 49
Of the ten TCP isomers, six contain ortho-methyl groups: TOCP
(Figure 1), di-ortho-cresyl-meta-cresyl phosphate (Figure 4), di-
ortho-cresyl-para-cresyl phosphate (Figure 5), di-meta-cresyl-
ortho-cresyl phosphate (Figure 6), di-para-cresyl-ortho-cresyl
phosphate (Figure 8) and ortho-cresyl-meta-cresyl-para-cresyl
phosphate (Figure 10). The neurotoxicity of only one of these isomers
(TOCP) has been addressed in depth. Further, the NTP Working
Group noted that the potential neurotoxicity of long-term, low-dose
occupational exposure to industrial products containing TCP has not
been investigated in a comprehensive manner. However, the Daughtrey
et al. and Kinkead et al. addressed the neurotoxic effects of long-term,
low-dose exposure to jet engine lubricants containing TOCP. Such
effects were not observed in either study.50
Based on the presence of the ortho-methyl groups, it may be
presumed that six of the ten TCP isomers are neurotoxicants.
Furthermore, if the NTP Working Group is correct regarding the
neurotoxicity of preparations containing a single ortho-methyl group,
then three of the isomers (di-meta-cresyl-ortho-cresyl phosphate, di-
para-cresyl-ortho-cresyl phosphate and ortho-cresyl- m eta- cresyl-
46 NTP, supra note 7.
47 Id.
48 Id.
49 See WHO, supra note 4.
50 See Kinkead, supra note 34; see also Daughtrey, supra note 37.
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para-cresyl phosphate) may be presumed to be more neurotoxic than
TOCP. Additional studies are required, however, to prove the validity
of these presumptions.
Such studies may be mandated in part by the fact that analysis of
substances for the presence of TOCP may not reveal the presence of
other ortho-methyl groups. 5 1 As a result, substances containing TCP
made from natural cresol isomers may contain as many as six
neurotoxicants, five of which may not be detected by tests intended to
detect the presence of the known neurotoxicant, TOCP.
Conclusions
Could the "Jake Walk Blues" reoccur? While such a massive
poisoning is unlikely, it is not impossible. Instead of a contaminated
product, however, a more likely scenario would be for such a situation
to reoccur based on an ongoing exposure to low doses of toxicants. For
example, in what may be characterized as a "good news/bad news"
study, Daughtrey et al. noted that long-term, low-dose exposure to jet
engine lubricants containing TCP did not produce OPIDN but did
result in NTE inhibition. Apparently the NTE inhibition (23% - 34%)
did not reach the threshold necessary to result in OPIDN (70%) or to
elicit neuropathic effects (45%-65%).52 The long-term effects of
NTE inhibition were not addressed.
Given the wide range of uses of TCP, the fact that TCP made from
natural cresol isomers may contain as many as six isomers that are (or
appear to be) neurotoxicants and the fact that very little is known about
five of the six isomers, industry in North American may wish to follow
the lead of the Japanese. Since 1971, the Japanese have manufactured
TCP utilizing only synthetic cresol isomers. 53 Because the synthetic
isomers do not contain the unwanted components that are present in
natural cresol isomers, the TCP produced using synthetic cresol isomers
does not contain the ten isomers discussed herein. This approach has
not been adopted in North America, apparently because synthetic
cresol isomers are more expensive than natural cresol isomers.54
51 See NTP, supra note 7.
52 See Daughtrey, supra note 37.
53 See WHO, supra note 4.
54 See NTP, supra note 7.
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The WHO Working Group noted that individual variability made
it impossible to establish a safe level of exposure to TOCP. It may be
presumed that such individual variability may exist with regard to the
other five TCP isomers that also appear to be neurotoxicants.
Consequently, it may be in the best interests of both the public and
those firms that manufacture TCP utilizing natural cresol isomers to
convert to the use of synthetic cresol isomers. The costs of not doing so,
especially if low levels of exposure over long periods of time result in
significant neurological or reproductive injury, may be politically,
legally and economically unacceptable.
